ACELYRIN Inc.
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Hidradenitis Suppurativa Study of Izokibep (NCT05905783) | ACELYRIN Inc. | 2023-06-22 |
| Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED) (NCT05683496) | ACELYRIN Inc. | 2023-02-14 |
| Psoriatic Arthritis Study of Izokibep (NCT05623345) | ACELYRIN Inc. | 2022-11-21 |
| Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis (NCT05384249) | ACELYRIN Inc. | 2022-08-23 |
| Hidradenitis Suppurativa Phase 2b Study of Izokibep (NCT05355805) | ACELYRIN Inc. | 2022-05-05 |
| A Trial of the Efficacy and Safety of Izokibep in the Treatment of Non-anterior Uveitis (NCT04706741) | ACELYRIN Inc. | 2022-01-06 |
| A Study to Investigate Efficacy, Tolerability and Safety of ABY-035 in Patients With Active Psoriatic Arthritis (NCT04713072) | ACELYRIN Inc. | 2020-08-04 |
Track ACELYRIN Inc. automatically
Every clearance here is in the API, with alerts when new ones post.